RobertStevenBuschMD
Endocrinology • Albany, NYDiabetes, Lipid Metabolism, Thyroid
Assistant Clinical Professor, Endocrinology, Albany Medical College
Dr. Busch is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Washington Ave
Ste 300
Albany, NY 12206Phone(518) 489-4704
- Is this information wrong?
Education & Training
Albany Medical CenterFellowship, Endocrinology, Diabetes and Metabolism, 1984- N Shore UResidency, 1981
- North Shore University HospitalInternship, Internal Medicine, 1978 - 1979
Perelman School of Medicine at the University of PennsylvaniaClass of 1978
Certifications & Licensure
NY State Medical License 1979 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Hudson Valley Magazine Castle Connolly, 2012-2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 01Slim, A.M.,Rastogi, A.,Burgner, A.,Ali, A.,Joyce, C.,Charytan, C.,Rizk, D.,Zieve, F.,Bonabi, G.,Umpierrez, G.,Ahmed, I.,Diab, I.A.,Larocque, J.,Rohlf, J.,Reed, J.C.,Middleton, J.P.,Pettis, K.,Akright, L.,...
- A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease Start of enrollment: 2012 Jul 01Soufer, J.,Terrelonge, A.E.,Seek, M.M.,Warren, M.,Aronoff, S.L.,Streja, D.A.,Fernandez-Bombino, J.A.,Numrungroad, V.,Shanik, M.H.,Moore, P.B.,Hetnal, C.,Venereo, J.M.,Scott, D.,Newman, G.E.,Mustafa, M.R.,...
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 01Osunkoya, A.,Salacata, A.,Anekwe, A.,Schnall, A.,Labroo, A.,Taylon, A.,Forker, A.,Kravitz, A.,Tannenbaum, A.,Higgins, A.,Rohatgi, A.,McWilliams, A.,Chang, A.,Jr, A.B.,Vo, A.,White, A.,Bhargava, A.,Jimenez...
Publications & Presentations
PubMed
- 42 citationsSemaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial.Bernard Zinman, Vaishali Bhosekar, Robert S. Busch, Ingrid Holst, Bernhard Ludvik, Desirée Thielke, James Thrasher, Vincent Woo, Athena Philis-Tsimikas> ;The Lancet Diabetes & Endocrinology. 2019 May 1
- GLP-1 receptor agonists, CKD, and eGFR trajectory - Authors' reply.Katherine R. Tuttle, Mark Lakshmanan, Brian Rayner, Robert S. Busch, Alan G. Zimmermann, D. Bradley Woodward, Fady T. Botros> ;The Lancet Diabetes & Endocrinology. 2018 Oct 1
- 128 citationsDulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trialKatherine R. Tuttle, Mark Lakshmanan, Brian Rayner, Robert S. Busch, Alan G. Zimmermann, D. Bradley Woodward, Fady T. Botros> ;The Lancet Diabetes & Endocrinology. 2018 Aug 1
- Join now to see all
Press Mentions
50 Things Doctors Would Tell Their Own MothersAugust 9th, 2019
Diabetes Increases the Risk of Heart Failure More in Women Than in MenJuly 22nd, 2019- Fish Oil Drug Drastically Lowers Heart Risks, According to New DataSeptember 25th, 2018
- Join now to see all
Hospital Affiliations
- Albany Memorial HospitalAlbany, New York
Albany Medical CenterAlbany, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
